Matches in Wikidata for { <http://www.wikidata.org/entity/Q94682492> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q94682492 description "artykuł naukowy opublikowany 14 maja 2020" @default.
- Q94682492 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q94682492 description "scientific article published on 14 May 2020" @default.
- Q94682492 description "wetenschappelijk artikel" @default.
- Q94682492 description "наукова стаття, опублікована 14 травня 2020" @default.
- Q94682492 name "Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial" @default.
- Q94682492 name "Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial" @default.
- Q94682492 type Item @default.
- Q94682492 label "Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial" @default.
- Q94682492 label "Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial" @default.
- Q94682492 prefLabel "Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial" @default.
- Q94682492 prefLabel "Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial" @default.
- Q94682492 P1433 Q94682492-B2CA9619-2DE6-4A29-95C4-6F1D237F68AA @default.
- Q94682492 P1476 Q94682492-BF3EB778-DF46-466C-9EE0-96B0B8CFB983 @default.
- Q94682492 P2093 Q94682492-02C38124-8E88-4894-928F-B775FF31502B @default.
- Q94682492 P2093 Q94682492-26A4D172-F55E-4C5D-8B26-D417786A1224 @default.
- Q94682492 P2093 Q94682492-2FFEE39F-2F6C-4895-A016-9B2EE8479CC7 @default.
- Q94682492 P2093 Q94682492-387CF1B2-442C-4F1C-BFA3-B8CCD168CF23 @default.
- Q94682492 P2093 Q94682492-432E6F02-1AA5-4B29-8FCB-EB41899E484E @default.
- Q94682492 P2093 Q94682492-5022BF69-0DB0-4958-915A-D2D390267FA8 @default.
- Q94682492 P2093 Q94682492-5A3F1A62-8672-41C5-9327-D7CCFCC53EB3 @default.
- Q94682492 P2093 Q94682492-67795576-7553-42E1-B7F3-D2A02FC62C58 @default.
- Q94682492 P2093 Q94682492-831B185E-1BAF-4116-B33F-08EA07065F90 @default.
- Q94682492 P2093 Q94682492-83A60BA3-CBC3-44BB-8B07-AB40AD687AE7 @default.
- Q94682492 P2093 Q94682492-9C4B8CED-1DA2-461B-8827-2FC8F2D0A712 @default.
- Q94682492 P2093 Q94682492-A6D743CB-0301-4C90-9ED8-376D23AC95F3 @default.
- Q94682492 P2093 Q94682492-A9E2CE79-524B-4D3A-B23D-345E4A941B1C @default.
- Q94682492 P2093 Q94682492-CE36FABB-28E0-432B-AFDD-F0322450C8DC @default.
- Q94682492 P2093 Q94682492-F891DABB-BC9C-47BB-B846-E4323CC5C4DA @default.
- Q94682492 P304 Q94682492-79A6D81F-34D4-46D3-BB48-BEEEEADA0DCE @default.
- Q94682492 P31 Q94682492-55312083-B335-4014-AC60-E706E37E17FC @default.
- Q94682492 P356 Q94682492-DB4A179A-87C8-43C0-8297-064526A7F097 @default.
- Q94682492 P433 Q94682492-E8609B2A-8CE6-45F9-A476-62BE14FCB886 @default.
- Q94682492 P478 Q94682492-D2419410-BE9C-4531-BEC0-8F9C83891CE4 @default.
- Q94682492 P50 Q94682492-2DDD2A12-7395-47BE-8B3C-16B1BD616DC4 @default.
- Q94682492 P577 Q94682492-5D025C21-5C1B-4E82-A27E-4ECBDEDA8AEB @default.
- Q94682492 P698 Q94682492-0EC57274-35E4-429C-A7F5-58CB89BAA1EA @default.
- Q94682492 P932 Q94682492-486C8620-CAED-422E-AC58-BD8B0EE56188 @default.
- Q94682492 P356 S13058-020-01283-W @default.
- Q94682492 P698 32408905 @default.
- Q94682492 P1433 Q2208481 @default.
- Q94682492 P1476 "Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial" @default.
- Q94682492 P2093 "Christgen Matthias" @default.
- Q94682492 P2093 "Clemens Michael" @default.
- Q94682492 P2093 "Feuerhake Friedrich" @default.
- Q94682492 P2093 "Gluz Oleg" @default.
- Q94682492 P2093 "Graeser Monika" @default.
- Q94682492 P2093 "Harbeck Nadia" @default.
- Q94682492 P2093 "Heinisch Fred" @default.
- Q94682492 P2093 "Kates Ronald" @default.
- Q94682492 P2093 "Kreipe Hans" @default.
- Q94682492 P2093 "Malter Wolfram" @default.
- Q94682492 P2093 "Nitz Ulrike" @default.
- Q94682492 P2093 "Nuding Benno" @default.
- Q94682492 P2093 "Reimer Toralf" @default.
- Q94682492 P2093 "Shak Steve" @default.
- Q94682492 P2093 "Wuerstlein Rachel" @default.
- Q94682492 P304 "47" @default.
- Q94682492 P31 Q13442814 @default.
- Q94682492 P356 "10.1186/S13058-020-01283-W" @default.
- Q94682492 P433 "1" @default.
- Q94682492 P478 "22" @default.
- Q94682492 P50 Q94682490 @default.
- Q94682492 P577 "2020-05-14T00:00:00Z" @default.
- Q94682492 P698 "32408905" @default.
- Q94682492 P932 "7227091" @default.